| DC Field | Value | Language |
|---|
| dc.contributor.author | Khokhlov, A. L. | - |
| dc.contributor.author | Yaichkov, I. I. | - |
| dc.contributor.author | Alexeev, M. A. | - |
| dc.contributor.author | Korsakov, M. K. | - |
| dc.contributor.author | Shetnev, A. A. | - |
| dc.date.accessioned | 2024-08-23T08:40:20Z | - |
| dc.date.available | 2024-08-23T08:40:20Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.citation | Identification and synthesis of metabolites of the new 4.5-dihydroisoxazol-5-carboxamide derivate / A.L. Khokhlov, I.I. Yaichkov, M.A. Alexeev [et al.] // Research Results in Pharmacology. - 2024. - Vol.10, №2.-P. 83-95. - Doi: 10.18413/rrpharmacology.10.482. - Refer.: p. 94. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/63422 | - |
| dc.description.abstract | 3-(2-butyl-5-chloro-1H-imidazole-4-yl)-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4,5- dihydro-1,2-oxazole-5-carboxamide is new antirheumatic drug. It is necessary to identify and synthesize the biotransformation products for its complete pharmacokinetic study | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | 4.5-dihydroisoxazol-5-carboxamide derivative | ru |
| dc.subject | biotransformation | ru |
| dc.subject | PAR-2 inhibitor | ru |
| dc.subject | hydrolysis | ru |
| dc.title | Identification and synthesis of metabolites of the new 4.5-dihydroisoxazol-5-carboxamide derivate | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 10, № 2
|
